[1]
Pomares, M.L., Gómez Martín, C., Muratore, M.C., Ávila, P.J., Apoloni, S.B., Mendez, E.G., Rubin, G., Maldini, A.C., Ruiz Morosini, M.L., Gorbán de Lapertosa, S., Sauer, L., Álvarez Fernández, F., Bendahan, J., Lequi, L., Linari, M.A., Sosa, V., Aranguren, M.F., González, J., Macello, G., Suppo, M., Vilte, J.A., Acosta, M.C.S., Dituro, C.F., Daín, A., Koleff, C.K., Figueredo, C., Esperanza, M.J., Llense, J., Dávila, F., Fuente, G., Gómez, S.S., Guercetti, R.A., Mantovan, M., Re, M., Puente Olivera, R., Salva, S.N., Burgos, N., Herrera, E., Kremer Sendros, S.A., Romero, E., Lorenzo, O.G., Rodríguez Cuimbra, S., Forte, E.H., González, C.D., Sociedad Argentina de Diabetes and Grupo de Estudio COVIDGRAD 2023. O7 Evaluation of the Degree of Anxiety and Stress in People with Type 1 and 2 Diabetes (T1D and T2D) during quarantine due to COVID-19 pandemic in Argentina. Journal of the Argentine Society of Diabetes. 54, 3Sup (Jan. 2023), 92–92. DOI:https://doi.org/10.47196/diab.v54i3Sup.368.